NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=124303&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com […]

Allied Gold Corporation (TSX: AAUC) (OTCQX: AAUCF)(“Allied” or the “Company”) herein provides its preliminary operating results for the fourth quarter ending December 31st, 2024. https://mma.prnewswire.com/media/2603316/Allied_Gold_Corporation_ALLIED_GOLD_ANNOUNCES_PRELIMINARY_2024_F.jpg Operational Highlights — Q4 Gold Production:The Company produced 99,632 ounces of gold in Q4, well in line with previously issued production guidance of 98,000 to 102,000 ounces. This result is

Blue Hour Studios' newest report guides brands on how to revise outmoded social media marketing strategies Swell.AI reimagines how social impact is measured, leveraging a psychographic approachfor more authentic content creation and stronger audience engagement While advertisers will spend $8.14 billion on influencer marketing in 2024, traditional demographic-based approaches are failing to deliver results, according

Trinity Capital Inc. (NASDAQ: TRIN) (“Trinity Capital” or the “Company”), a leading alternative asset manager, today announced that its equipment finance vertical has surpassed $1 billion in fundings to high-growth companies since 2018. This milestone underscores the Company's commitment to supporting the growth and innovation of businesses in a variety of industries, including manufacturing &

L&C Bio (CEOHwan-Chul Lee) has achieved a significant milestone in its global market strategy by becoming the first company worldwide to secure approval from China's National Medical Products Administration (NMPA) for its acellular dermal matrix, “MegaDerm Plus.” This approval positions the company to potentially dominate China's regenerative medicine market for human tissue, with full-scale sales

Company's Connected Platform on Full Display in Booth 1426 at the 2025 NADA Show This Month Cars.com Inc. (NYSE: CARS) (d/b/a “Cars Commerce”), an audience-driven technology company empowering automotive, shares new data about the value of its connected platform. Dealer customers taking advantage of more than one of the platform's four core capabilities (Marketplace, Digital

(NASDAQ:ICU), DENVER, Jan. 22, 2025 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that Mayo Clinic is now cleared to enroll subjects in the company's NEUTRALIZE-AKI pivotal trial, increasing the number of activated sites to 15.

(TSX-V:RKV), VANCOUVER, British Columbia, Jan. 22, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company at the forefront of AI-driven drug discovery, yesterday commented on the announcement of a $500 billion private-sector investment into AI infrastructure by OpenAI, SoftBank, and Oracle through their joint venture, Stargate. This historic initiative marks a defining

(NasdaqGM:FCEL), DANBURY, Conn., Jan. 22, 2025 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL), a Connecticut-based global leader in delivering clean, innovative fuel cell solutions for the supply, recovery, and storage of energy, announced that it will build a 7.4 MW fuel cell power plant in Hartford, Conn. The project will deliver Class 1 renewable

(NASDAQ:ELTX), Received supportive FDA feedback on key elements of the potential ELI-002 Phase 3 study design, including dose, schedule, patient population and primary endpoint analysis Phase 2 randomized study of ELI-002 fully enrolled, with formal interim analysis of disease-free survival (“DFS”) expected in H1 2025; positive results could support rapid advancement into Phase 3 development